Concepedia

Combination of temozolomide (TMZ) and irinotecan (CPT-11) showed enhanced activity for recurrent malignant gliomas: A North American Brain Tumor Consortium (NABTC) phase II study

W.K. Alfred Yung, Frank S. Lieberman, Patrick Y. Wen, Isabelle Robin, M. R. Gilbert, S. Chang, Larry Junck, Timothy F. Cloughesy, Kathleen R. Lamborn, Michael Prados

Journal of Clinical Oncology · 2005 · 16 citations · 0 references

DOI

Concepts

Abstract

1521